BioNexus Gene Lab Corp Common stock (NASDAQ: BGLC) last traded at $1.59, up 0.22% on the session. The quote above updates while this page is open; the figures below are drawn from BioNexus Gene Lab Corp Common stock’s own filings and are restated only when a new one is published.
BioNexus Gene Lab Corp Common stock trades on NASDAQ under the ticker BGLC. Its market capitalisation is $4.66 million.
Valuation measures for BioNexus Gene Lab Corp Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.66M |
|---|---|
| Enterprise value | $4.38M |
| Price / sales | 1.49 |
| Price / book | 0.60 |
| Beta | 1.27 |
Trailing-twelve-month figures tagged in BioNexus Gene Lab Corp Common stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.13M |
|---|---|
| Net income (TTM) | -$2.58M |
| Gross margin | 12.34% |
| Operating margin | -81.82% |
| Return on equity | -33.11% |
| Cash | $1.23M |
Range and volume for BGLC over the past 52 weeks.
| 52-week high | $6.10 |
|---|---|
| 52-week low | $1.07 |
| Volume | 985 |
| Average volume | 102.6K |
| Previous close | $1.59 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.